Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use MAYZENT safely and effectively. See full prescribing information for MAYZENT. MAYZENT® (siponimod) tablets, for oral use Initial U.S. Approval: 2019
Medication labelWhy this: Advisory · dailymed-prescription
MAYZENT is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
- generic_name
- siponimod
- product_names
- siponimod
- ndc
- 0078-0979, 0078-0979-50, 0078-0979-12, 0078-0979-92, 0078-0979-89, 0078-1014, 0078-1014-15, 0078-1014-93, 0078-0986, 0078-0986-15, 0078-0986-93, 0078-0986-45, 0078-0986-94
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en